Retour
Fourchette du Jour
4,03 €
4,40 €
Fourchette 52 Semaines
1,00 €
5,82 €
Volume
250
Moyenne 50J / 200J
4,89 €
/
4,18 €
Clôture Précédente
4,03 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,0 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -50,7 | 3,9 |
| Rev Growth 5Y % | 58,2 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,05 €
0,04 € – 0,06 €
|
630 M | 1 |
| FY2029 |
0,05 €
0,04 € – 0,06 €
|
530 M | 1 |
| FY2028 |
-0,05 €
-0,06 € – -0,04 €
|
410 M | 1 |
Points Clés
Revenue grew 58,15% annually over 5 years — strong growth
Negative free cash flow of -167,05M
PEG of 0,12 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38,37%
Capital efficient — spends only 6,25% of revenue on capex
Croissance
Revenue Growth (5Y)
58,15%
Revenue (1Y)96,52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-67,16%
Net Margin-50,68%
Op. Margin-52,64%
Sécurité
Debt / Equity
N/A
Current Ratio1,39
Interest Coverage-2,73
Valorisation
P/E Ratio
-8,95
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 96,52% | Revenue Growth (3Y) | 20,46% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58,15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 221,11M | Net Income (TTM) | -112,05M |
| ROE | N/A | ROA | -24,05% |
| Gross Margin | 90,31% | Operating Margin | -52,64% |
| Net Margin | -50,68% | Free Cash Flow (TTM) | -167,05M |
| ROIC | -67,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,39 |
| Interest Coverage | -2,73 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,95 | P/B Ratio | N/A |
| P/S Ratio | 4,54 | PEG Ratio | 0,12 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,00B | Enterprise Value | 2,18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 221,11M | 112,51M | 152,39M | 97,10M | 35,35M |
| Net Income | -112,05M | -263,76M | -297,92M | -827,90M | -634,60M |
| EPS (Diluted) | -0,52 | -1,45 | -1,67 | -4,67 | -3,77 |
| Gross Profit | 199,67M | 76,58M | 145,24M | 90,84M | 17,32M |
| Operating Income | -116,38M | -232,01M | -255,15M | -802,97M | -613,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 465,88M | 505,90M | 500,00M | 904,18M | 1,48B |
| Total Liabilities | 1,60B | 1,72B | 1,47B | 1,57B | 1,38B |
| Shareholders' Equity | -1,14B | -1,21B | -968,72M | -660,96M | 104,20M |
| Total Debt | 1,27B | 1,26B | 1,20B | 1,23B | 1,16B |
| Cash & Equivalents | 87,24M | 105,38M | 145,05M | 146,00M | 101,35M |
| Current Assets | 223,81M | 255,48M | 276,28M | 596,44M | 1,08B |
| Current Liabilities | 160,86M | 443,20M | 301,33M | 170,36M | 165,14M |